Delcath raises $2m in Series B stock sale

Delcath Systems (NSDQ:DCTH) has raised $2 million after selling 2,360 shares of Series B preferred stock at $1,000 per share to unnamed institutional investors, according to a regulatory filing.

The company wrote that it plans to use the proceeds for general corporate purposes.

Get the full story at our sister site, Drug Delivery Business News.

The post Delcath raises $2m in Series B stock sale appeared first on MassDevice.

from MassDevice http://ift.tt/2sQzCLD